Financhill
Buy
54

PCVX Quote, Financials, Valuation and Earnings

Last price:
$46.51
Seasonality move :
4.77%
Day range:
$45.11 - $46.79
52-week range:
$27.66 - $94.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.10x
Volume:
1.1M
Avg. volume:
1.5M
1-year change:
-48.38%
Market cap:
$6.1B
Revenue:
--
EPS (TTM):
-$4.92

Earnings Data

Next earnings date for PCVX
Feb 24
2026
Most recent earnings per share
-$1.56
Missed by $0.33
(Nov 4/2025)
Consensus Estimate
-$1.24
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PCVX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/24/2026 Q4 -- -- -- -$1.45 --
11/04/2025 Q3 -- -- -$1.56 -$1.24 -$0.33
08/06/2025 Q2 -- -- -$1.22 -$1.16 -$0.06
05/08/2025 Q1 -- -- -$1.04 -$0.98 -$0.06
02/25/2025 Q4 -- -- -$1.10 -$0.99 -$0.11
11/05/2024 Q3 -- -- -$0.83 -$0.99 $0.16
08/06/2024 Q2 -- -- -$1.10 -$1.02 -$0.08
05/08/2024 Q1 -- -- -$0.85 -$1.06 $0.21
02/27/2024 Q4 -- -- -$1.90 -$0.99 -$0.90
11/06/2023 Q3 -- -- -$0.91 -$0.84 -$0.07
08/08/2023 Q2 -- -- -$0.70 -- --
05/08/2023 Q1 -- -- -$0.70 -- --
02/27/2023 Q4 -- -- -$1.03 -- --
11/07/2022 Q3 -- -- -$0.93 -- --
08/08/2022 Q2 -- -- -$0.80 -- --
05/09/2022 Q1 -- -- -$0.68 -- --
02/28/2022 Q4 -- -- -$0.54 -- --
11/10/2021 Q3 -- -- -$0.51 -- --
08/11/2021 Q2 -- -- -$0.46 -- --
05/11/2021 Q1 -- -- -$0.41 -- --
03/29/2021 Q4 -- -- -$0.41 -- --
11/12/2020 Q3 -- -- -$0.41 -- --
08/12/2020 Q2 -- -- -$0.40 -- --
03/31/2020 Q1 -- -- -$0.56 -- --
12/31/2019 Q4 -- -- -$0.30 -- --
09/30/2019 Q3 -- -- -$0.23 -- --
06/30/2019 Q2 -- -- -$0.21 -- --
03/31/2019 Q1 -- -- -$0.28 -- --

Vaxcyte, Inc. Earnings Questions

  • How Much did Vaxcyte, Inc. Generate in Revenue Last Quarter?

    Vaxcyte, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Vaxcyte, Inc. Beat Earnings Last Quarter?

    Vaxcyte, Inc. announced earnings per share of -$1.56 which represents a miss of analyst forecast a -$1.24 per share.

  • Is Vaxcyte, Inc. Profitable?

    Vaxcyte, Inc. reported -$5.2M that represents -$0.04 per share over the last quarter.

  • What is the Analyst Consensus for Vaxcyte, Inc. EPS Next Year?

    Vaxcyte, Inc.'s earnings are forecast to decrease from -$3.80 per share to -$3.91 per share next year representing a decrease of -39.55%.

  • When is Vaxcyte, Inc.'s Earnings Date?

    Vaxcyte, Inc.'s next earnings date is February 24, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock